Medical Affairs Policy

Size: px
Start display at page:

Download "Medical Affairs Policy"

Transcription

1 Service: Acupuncture Therapy PUM Medical Affairs Policy Medical Policy Committee Approval 03/16/18 Effective Date 07/01/18 Prior Authorization Needed Yes-if not an exclusion of the health plan Note: Acupuncture is often a specific exclusion of the member s health plan. Consult the member's benefit plan to determine if there are any exclusions or other benefit limitations applicable to this service Disclaimer: This policy is for informational purposes only and does not constitute medical advice, plan authorization, an explanation of benefits, or a guarantee of payment. Benefit plans vary in coverage and some plans may not provide coverage for all services listed in this policy. Coverage decisions are subject to all terms and conditions of the applicable benefit plan, including specific exclusions and limitations, and to applicable state and federal law. Some benefit plans administered by the organization may not utilize Medical Affairs medical policy in all their coverage determinations. Contact customer services as listed on the member card for specific plan, benefit, and network status information. Medical policies are based on constantly changing medical science and are reviewed annually and subject to change. The organization uses tools developed by third parties, such as the evidence-based clinical guidelines developed by MCG to assist in administering health benefits. This medical policy and MCG guidelines are intended to be used in conjunction with the independent professional medical judgment of a qualified health care provider. To obtain additional information about MCG, medical.policies@wpsic.com. Description: Acupuncture is a therapeutic procedure that involves the strategic placement of needles to stimulate specific anatomical locations of the body, with the goal of relieving pain or treating disease. The scientific literature regarding the effectiveness of acupuncture continues to be insufficient, conflicting, and from uncontrolled studies, small case series, case reports, and anecdotal information. Some randomized trials suggest that acupuncture and sham acupuncture may have similar efficacy. Flaws in study design and reporting, the heterogeneity of treatment methods, clinical differences between trials, and lack of clear measurable outcomes continue to prevent conclusions about the efficacy and long-term outcomes. Further studies with better methodological quality are still needed. Reports regarding safety conclude that acupuncture provided by a certified acupuncturist is generally considered safe, if appropriate sterile techniques are followed. Consequently, there are professional society recommendations that patients interested in or open to acupuncture may be referred for a trial of acupuncture when the availability of safe alternatives is limited. Page 1 of 5

2 Indications of Coverage: In the absence of health plan exclusions, specific coverage indications or visit limits, a maximum of twelve (12) acupuncture treatments will be approved in a consecutive 12- month period. Limitations of Coverage: A. Review contract and endorsements for exclusions and prior authorization or benefit requirements. B. More than twelve acupuncture treatments is considered not medically necessary. C. Acupressure wristbands are non-prescription devices that are considered experimental, investigational, and unproven to affect health outcomes. Documentation Required: Office notes: Treatment plan showing specific treatment goals, expected number and frequency of treatment visits, and objective signs/ measures documenting efficacy of treatment. References: 1. Agency for Healthcare Research and Quality (AHRQ). Acupuncture for fibromyalgia. Technology assessment Jun. Available at: Accessed: 14 Dec Agency for Healthcare Research and Quality (AHRQ). Acupuncture for osteoarthritis. Technology assessment Jun. Available at: 14 Dec Centers for Medicare & Medicaid Services (CMS). National Coverage Determination (NCD): Acupuncture. NCD Baltimore, MD. Effective date: N/A. Available at: Accessed: 12 Dec Ernst E. Acupuncture - a critical analysis. Journal of Internal Medicine. 2006; 259(2): Ernst E. Acupuncture: what does the most reliable evidence tell us? J Pain Symptom Manage Apr; 37(4): Page 2 of 5

3 6. Furlan AD, van Tulder MW, Cherkin DC, Tsukayama H, Lao L, Koes BW, Berman BM. Acupuncture and dry-needling for low back pain. The Cochrane Database of Systematic Reviews 2006 Issue Hayes Medical Technology Directory. Acupuncture for the Treatment of Pain. Lansdale, Pa: Hayes, Inc.; 2006 Winifred S. Hayes, Inc Jan. Updated January 7, Archived Feb 20, Lewis K, Abdi S. Acupuncture for lower back pain: a review. Clin J Pain Jan; 26(1): Madsen MV, Gotzsche PC, Hrobjartsson A. Acupuncture treatment for pain: systematic review of randomized clinical trials with acupuncture, placebo acupuncture, and no acupuncture groups. BMJ Jan 27; 338:a Manheimer E, White A, Berman B, Forys K, Ernst E. Meta-analysis: acupuncture for low back pain. Ann Intern Med Apr 19; 142(8); National Center for Complementary and Alternative Medicine. Acupuncture for Pain. Updated: August Available at: nccam.nih.gov/health/acupuncture/acupuncture-for-pain.htm. Accessed: 14 Dec National Institutes of Health (NIH). Acupuncture. Consensus statement online Nov 3-5; 15(5):1-34. Available at: Consensus.nih.gov/1997/1997Acupuncture107html.htm. Accessed: 5 Jan Matthews A, Dowswell T, Haas DM, Doyle M, O'Mathúna DP. Interventions for nausea and vomiting in early pregnancy. Cochrane Database of Systematic Reviews 2010, Issue 9. Art. No.: CD DOI: / CD pub2. Assessed as up to date June Available at Accessed 6 Jan, Hayes Medical Technology Directory. Acupuncture and Acupressure for the Treatment of Nausea and Vomiting. June 14, Annual Review: May 21, 2014, Archived July 15, UpToDate. Treatment and outcome of nausea and vomiting of pregnancy. Literature review current through: Jan 2018 This topic last updated: Jan 17, UpToDate. Complementary and alternative therapies for cancer. Literature review current through: Dec This topic last updated: Aug 31, Page 3 of 5

4 17. UpToDate. Acupuncture. Literature review current through Jan Topic last updated Apr 20, UpToDate Treatment of Urinary incontinence in women. Literature review current through Jan Topic last updated Jan 25, Acupuncture. MCG Ambulatory Care 22nd Ed. A-0329 (AC) Acupuncture. 20. InterQual Clinical Evidence Summary. Copyright Acupuncture. 21. Hayes Medical Technology Directory. Acupuncture for Assisted Reproduction. Publication Date July 15, Annual Review June 5, 2014, June 05, Archived Aug 15, Hayes Medical Technology Directory. Acupuncture for Neck and Shoulder Pain. Publication Date Dec 27, Annual Review Feb 3, 2014, Archived Jan 27, Hayes Medical Technology Directory. Acupuncture for Treatment of Low Back Pain. Publication Date Oct 21, Annual Review Sept 8, 2014, Archived Nov 21, Hayes Health Technology Brief P-stim Auricular Electroacupuncture for Pain Management. Publication date Dec 31, 2012 Annual review Dec 10, 2014, Archived Jan 31, Hayes Technology Brief Acupuncture for Treatment of Chronic Obstructive Pulmonary Disease (COPD). Publication Date: August 5, 2013 Annual Review: June 30, 2015, Archived Sep 03, WPS / Arise Review History: Implemented 04/04/14, 04/17/15, 07/01/16, 07/01/17, 07/01/18 Reviewed 03/13/15, 03/11/16, 03/17/17, 03/16/18 Revised 03/07/14, 03/17/17, 03/16/18 Developed Medical Policy 03/07/14, 03/13/15, 03/11/16, 03/17/17, 03/16/18 Committee Approval Note: For review/revision history prior to 2014 see previous Medical Policy or Coverage Policy Bulletin Approved by the Medical Director Page 4 of 5

5 Page 5 of 5

Medical Affairs Policy

Medical Affairs Policy Medical Affairs Policy Service: Blepharoplasty, Blepharoptosis Repair, Brow lift, and Related Procedures PUM 250-0004 Medical Policy Committee Approval 03/17/17 Effective Date 07/01/17 Prior Authorization

More information

Medical Affairs Policy

Medical Affairs Policy Medical Affairs Policy Service: Blepharoplasty, Blepharoptosis Repair, Brow lift, and Related Procedures PUM 250-0004 Medical Policy Committee Approval 03/16/18 Effective Date 07/01/18 Prior Authorization

More information

Clinical Policy: Acupuncture Reference Number: PA.CP.MP.92

Clinical Policy: Acupuncture Reference Number: PA.CP.MP.92 Clinical Policy: Reference Number: PA.CP.MP.92 Effective Date: 01/18 Last Review Date: 11/18 Coding Implications Revision Log Description involves the manual and/or electrical stimulation of thin, solid,

More information

Medical Affairs Policy

Medical Affairs Policy Medical Affairs Policy Service: Omnibus Pharmacy Policy for Treatments Reviewed by Medical Affairs PUM 250-0037-1712 Medical Policy Committee Approval 12/01/17 Effective Date 04/01/18 Prior Authorization

More information

Clinical Policy: Acupuncture Reference Number: CP.MP.92

Clinical Policy: Acupuncture Reference Number: CP.MP.92 Clinical Policy: Reference Number: CP.MP.92 Effective Date: 12/13 Last Review Date: 11/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and

More information

Medical Affairs Policy

Medical Affairs Policy Medical Affairs Policy Service: Corneal Treatments and Specialized Contact Lenses (Corneal remodeling, Corneal transplant, Corneal collagen crosslinking, Intrastromal Rings- INTACS, Keratoconus treatments,

More information

Medical Affairs Policy

Medical Affairs Policy Medical Affairs Policy Service: Back Pain Procedures-Epidural Injection (Caudal Epidural, Selective Nerve Root Block, Interlaminar, Transforaminal, Translaminar Epidural Injection) PUM 250-0015-1706 Medical

More information

Appendix Studies of the Efficacy of Acupuncture *

Appendix Studies of the Efficacy of Acupuncture * Appendix Studies of the Efficacy of Acupuncture * Study Study Description Main Results Researchers Conclusions Lee A, Fan LT. Stimulation of wrist acupuncture point P6 for preventing nausea and vomiting.

More information

Medical Affairs Policy

Medical Affairs Policy Medical Affairs Policy Service: Cochlear Implants, Bone Anchored Hearing Aids (BAHA), Auditory Brainstem Implants, and Other Hearing Assistive Devices PUM 250-0014 Medical Policy Committee Approval 06/15/18

More information

Medical Affairs Policy

Medical Affairs Policy Medical Affairs Policy Service: Back Pain: Sacroiliac and Coccydynia Treatments PUM 250-0024-1706 Medical Policy Committee Approval 06/15/18 Effective Date 10/01/18 Prior Authorization Needed Yes Disclaimer:

More information

3. Treatment guidelines: Initial treatment: A total of 3-4 visits over 2 weeks may be considered medically necessary

3. Treatment guidelines: Initial treatment: A total of 3-4 visits over 2 weeks may be considered medically necessary HCT Medical Policy Acupuncture for the Treatment of Pain Policy # HCT112 Current Effective Date: 2/21/2015 Medical Policies are developed by HealthyCT to assist in administering plan benefits and constitute

More information

Medical Affairs Policy

Medical Affairs Policy Medical Affairs Policy Service: Urine Drug/Alcohol Screening and Testing PUM 250-0013-1803 Medical Policy Committee Approval 03/06/18 Effective Date 07/01/18 Prior Authorization Needed No Disclaimer: This

More information

Clinical Policy: Trigger Point Injections for Pain Management

Clinical Policy: Trigger Point Injections for Pain Management Clinical Policy: for Pain Management Reference Number: CP.MP.169 Last Review Date: 08/18 See Important Reminder at the end of this policy for important regulatory and legal information. Coding Implications

More information

Medical Affairs Policy

Medical Affairs Policy Medical Affairs Policy Service: Infertility and Recurrent Pregnancy Loss Testing and Treatment PUM 250-0018-1706 Medical Policy Committee Approval 06/16/17 Effective Date 10/01/17 Prior Authorization Needed

More information

Arise Medical Policy Updates

Arise Medical Policy Updates Arise Medical Policy Updates The Medical Affairs Medical Policy Committee approved medical policies on March 16, 2018. The policies become effective July 1, 2018, unless otherwise noted below. Disclaimer:

More information

POLICIES AND PROCEDURE MANUAL

POLICIES AND PROCEDURE MANUAL POLICIES AND PROCEDURE MANUAL Policy: MP230 Section: Medical Benefit Policy Subject: Outpatient Pulmonary Rehabilitation I. Policy: Outpatient Pulmonary Rehabilitation II. Purpose/Objective: To provide

More information

ACUPUNCTURE THE EVIDENCE

ACUPUNCTURE THE EVIDENCE SUMMARY OF THE CURRENT EVIDENCE ON ACUPUNCTURE FOR MUSCULOSKELETAL CONDITIONS Summary In this Summary we present an overview that includes the most recent evidence on acupuncture for musculo-skeletal conditions

More information

Clinical Policy: Low-Frequency Ultrasound Therapy for Wound Management Reference Number: CP.MP.139 Last Review Date: 01/18

Clinical Policy: Low-Frequency Ultrasound Therapy for Wound Management Reference Number: CP.MP.139 Last Review Date: 01/18 Clinical Policy: Low-Frequency Ultrasound Therapy for Wound Management Reference Number: CP.MP.139 Last Review Date: 01/18 See Important Reminder at the end of this policy for important regulatory and

More information

Medical Affairs Policy

Medical Affairs Policy Medical Affairs Policy Service: Sleep Disorder Treatment: Positive Airway Pressure Devices and Oral Appliances (CPAP, BPAP, BiPAP, BiPAP ST, BiPAP with backup, BiPAP -Auto SV, VPAP, VPAP Adapt, VPAP adapt

More information

Subject: Gastrointestinal Electrical Stimulation (GES) and Vagus Nerve Blocking Therapy (VBLOC) for Obesity. Original Effective Date: 7/8/2015

Subject: Gastrointestinal Electrical Stimulation (GES) and Vagus Nerve Blocking Therapy (VBLOC) for Obesity. Original Effective Date: 7/8/2015 Subject: Gastrointestinal Electrical Stimulation (GES) and Vagus Nerve Blocking Therapy (VBLOC) for Obesity Original Effective Date: 7/8/2015 Policy Number: MCP-243 Revision Date(s): Review Date: 12/16/15,

More information

Report to the Vermont General Assembly: Insurance Coverage for Acupuncture

Report to the Vermont General Assembly: Insurance Coverage for Acupuncture Report to the Vermont General Assembly: Insurance Coverage for Acupuncture Section 15 of Act No. 173, 2015 (Adj. Sess.), An act relating to combating opioid abuse in Vermont, directs Blue Cross and Blue

More information

Subject: Bronchial Thermoplasty

Subject: Bronchial Thermoplasty Subject: Bronchial Thermoplasty Guidance Number: MCG-171 Revision Date(s): Original Effective Date: 6/12/14 Medical Coverage Guidance Approval Date: 6/12/14 PREFACE This Medical Guidance is intended to

More information

BRONCHIAL THERMOPLASTY

BRONCHIAL THERMOPLASTY BRONCHIAL THERMOPLASTY UnitedHealthcare Community Plan Medical Policy Policy Number: CS014.E Effective Date: July 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS... 1 COVERAGE

More information

Sympathetic Electrical Stimulation Therapy for Chronic Pain

Sympathetic Electrical Stimulation Therapy for Chronic Pain Sympathetic Electrical Stimulation Therapy for Chronic Pain Policy Number: 015M0076A Effective Date: April 01, 015 RETIRED 5/11/017 Table of Contents: Page: Cross Reference Policy: POLICY DESCRIPTION COVERAGE

More information

Clinical Policy: Caudal or Interlaminar Epidural Steroid Injections

Clinical Policy: Caudal or Interlaminar Epidural Steroid Injections Clinical Policy: Reference Number: CP.MP.164 Last Review Date: 04/18 See Important Reminder at the end of this policy for important regulatory and legal information. Coding Implications Revision Log Description

More information

CADTH RAPID RESPONSE REPORT: REFERENCE LIST Side Effect Free Chemotherapy for the Treatment of Cancer: Clinical Effectiveness

CADTH RAPID RESPONSE REPORT: REFERENCE LIST Side Effect Free Chemotherapy for the Treatment of Cancer: Clinical Effectiveness CADTH RAPID RESPONSE REPORT: REFERENCE LIST Side Effect Free Chemotherapy for the Treatment of Cancer: Clinical Effectiveness Service Line: Rapid Response Service Version: 1.0 Publication Date: August

More information

TITLE: Chiropractic Interventions for Acute or Chronic Lower Back Pain in Adults: A Review of the Clinical and Cost-Effectiveness

TITLE: Chiropractic Interventions for Acute or Chronic Lower Back Pain in Adults: A Review of the Clinical and Cost-Effectiveness TITLE: Chiropractic Interventions for Acute or Chronic Lower Back Pain in Adults: A Review of the Clinical and Cost-Effectiveness DATE: 10 February 2009 CONTEXT AND POLICY ISSUES: Low back pain (LBP) is

More information

Pharmacy Medical Necessity Guidelines: Migraine Medications

Pharmacy Medical Necessity Guidelines: Migraine Medications Pharmacy Medical Necessity Guidelines: Effective: September 18, 2017 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX) or Medical (MED)

More information

Tri-County Opioid Safety Coalition Data Brief December 2017 Clackamas, Multnomah, and Washington Counties

Tri-County Opioid Safety Coalition Data Brief December 2017 Clackamas, Multnomah, and Washington Counties Medicaid-Funded Alternative Treatment for Back Pain in the Tri-County Region Key Findings The percentage of members with a back pain diagnosis who received an alternative treatment increased from 29% in

More information

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: March 1, Related Policies None

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: March 1, Related Policies None DRUG TESTING POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE 259.3 T0 Effective Date: March 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES OF

More information

Peripheral Subcutaneous Field Stimulation

Peripheral Subcutaneous Field Stimulation Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

Clinical Policy: Facet Joint Interventions

Clinical Policy: Facet Joint Interventions Clinical Policy: Reference Number: CP.MP.171 Last Review Date: 07/18 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description

More information

Peripheral Subcutaneous Field Stimulation. Description

Peripheral Subcutaneous Field Stimulation. Description Subject: Peripheral Subcutaneous Field Stimulation Page: 1 of 6 Last Review Status/Date: June 2016 Peripheral Subcutaneous Field Stimulation Description Peripheral subcutaneous field stimulation (PSFS,

More information

Clinical Policy Title: Radiofrequency ablation treatment for spine pain

Clinical Policy Title: Radiofrequency ablation treatment for spine pain Clinical Policy Title: Radiofrequency ablation treatment for spine pain Clinical Policy Number: 03.02.02 Effective Date: June 1, 2013 Initial Review Date: March 21, 2013 Most Recent Review Date: March

More information

MedStar Health considers Continuous Home Pulse Oximetry medically necessary for the following indications:

MedStar Health considers Continuous Home Pulse Oximetry medically necessary for the following indications: MedStar Health, Inc. POLICY AND PROCEDURE MANUAL MP.006.MH Continuous Home Pulse Oximetry This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP MedStar

More information

Assembly Bill 89. Requires Coverage of Acupuncture C-1

Assembly Bill 89. Requires Coverage of Acupuncture C-1 Assembly Bill 89 Requires Coverage of Acupuncture C-1 History State of NV has licensed Acupuncturists since 1973. We were the first state to do so. State of NV Health Insurance has covered acupuncture

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Policy Reference Number: CP.PMN.53 Effective Date: 09.12.17 Last Review Date: 11.18 Line of Business: Medicaid, HIM-Medical Benefit Revision Log See Important Reminder at the end of this

More information

Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital

Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital Dawn Waddell, PharmD, BCPS Clinical Pharmacy Manager Lisa Kingdon, PharmD, BCPS Clinical Pharmacy Specialist Dawn Waddell

More information

Clinical Policy: Disc Decompression Procedures Reference Number: CP.MP.114

Clinical Policy: Disc Decompression Procedures Reference Number: CP.MP.114 Clinical Policy: Reference Number: CP.MP.114 Effective Date: 07/16 Last Review Date: 07/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and

More information

HYSTERECTOMY FOR BENIGN CONDITIONS

HYSTERECTOMY FOR BENIGN CONDITIONS UnitedHealthcare Commercial Medical Policy HYSTERECTOMY FOR BENIGN CONDITIONS Policy Number: 2018T0572G Effective Date: September 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

Peripheral Subcutaneous Field Stimulation

Peripheral Subcutaneous Field Stimulation Peripheral Subcutaneous Field Stimulation Policy Number: 7.01.139 Last Review: 3/2018 Origination: 7/2013 Next Review: 9/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide

More information

Clinical Policy: Caudal or Interlaminar Epidural Steroid Injections

Clinical Policy: Caudal or Interlaminar Epidural Steroid Injections Clinical Policy: Reference Number: PA.CP.MP.164 Effective Date: 09/18 Last Review Date: 09/18 Coding Implications Revision Log Description Epidural steroid injections have been used for pain control in

More information

Recent Progress in Clinical Research of Acupuncture

Recent Progress in Clinical Research of Acupuncture 23 28 2009 1 Recent Progress in Clinical Research of Acupuncture Adrian WHITE Clinical Research Fellow, General practice and Primary Care, Institute of Health and Social Care, Peninsula Medical School,

More information

TITLE: Use of Bupropion in Patients with Depression and the Associated Risk of Seizures: Safety

TITLE: Use of Bupropion in Patients with Depression and the Associated Risk of Seizures: Safety TITLE: Use of Bupropion in Patients with Depression and the Associated Risk of Seizures: Safety DATE: 1 April 2010 CONTEXT AND POLICY ISSUES: The prevalence of epilepsy ranges from 0.5% to 1%, 1,2 and

More information

Premier Health Plan considers Intravascular Ultrasound (IVUS) for Coronary Vessels medically necessary for the following indications:

Premier Health Plan considers Intravascular Ultrasound (IVUS) for Coronary Vessels medically necessary for the following indications: Premier Health Plan POLICY AND PROCEDURE MANUAL MP.091.PH - Intravascular Ultrasound for Coronary Vessels This policy applies to the following lines of business: Premier Commercial Premier Employee Premier

More information

Product Name or Headline

Product Name or Headline Product Name or Headline Subhead goes here Payer policies will vary and should be verified prior to treatment for limitations on diagnosis, coding, or site of service requirements. The coding options listed

More information

MEDICAL POLICY Acupuncture

MEDICAL POLICY Acupuncture POLICY: PG0382 ORIGINAL EFFECTIVE: 12/13/16 LAST REVIEW: 06/12/18 MEDICAL POLICY Acupuncture GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each individual

More information

MOTORIZED SPINAL TRACTION

MOTORIZED SPINAL TRACTION MOTORIZED SPINAL TRACTION UnitedHealthcare Commercial Medical Policy Policy Number: PAI010 Effective Date: January 1, 2019 Table of Contents Page COVERAGE RATIONALE... 1 APPLICABLE CODES... 1 DESCRIPTION

More information

Clinical Policy: Robotic Surgery Reference Number: CP.MP. 207

Clinical Policy: Robotic Surgery Reference Number: CP.MP. 207 Clinical Policy: Robotic Surgery Reference Number: CP.MP. 207 Effective Date: 03/05 Last Review Date: 10/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important

More information

Clinical Policy: Clobazam (Onfi) Reference Number: CP.PMN.54. Line of Business: Medicaid

Clinical Policy: Clobazam (Onfi) Reference Number: CP.PMN.54. Line of Business: Medicaid Clinical Policy: (Onfi) Reference Number: CP.PMN.54 Effective Date: 11/12 Last Review Date: 05/17 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the end of this policy

More information

Corporate Medical Policy Investigational (Experimental) Services

Corporate Medical Policy Investigational (Experimental) Services Corporate Medical Policy Investigational (Experimental) Services File Name: Origination: investigational_(experimental)_services 1/1996 Description of Procedure or Service BCBSNC defines the terms "investigational"

More information

Coverage Guideline. BioniCare System (formerly the BIO-1000 System) DEFINITION COVERAGE CRITERIA MEDICAL BACKGROUND

Coverage Guideline. BioniCare System (formerly the BIO-1000 System) DEFINITION COVERAGE CRITERIA MEDICAL BACKGROUND Coverage Guideline System (formerly the BIO-1000 System) Disclaimer: Please note that Baptist Health Plan updates Coverage Guidelines throughout the year. A printed version may not be most up to date version

More information

Authors' objectives To evaluate the efficacy of complementary and alternative therapies for the management of menopausal symptoms.

Authors' objectives To evaluate the efficacy of complementary and alternative therapies for the management of menopausal symptoms. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review Nedrow A, Miller J, Walker M, Nygren P, Huffman L H, Nelson H D CRD summary This review

More information

Clinical Policy: Digital Breast Tomosynthesis Reference Number: CP.MP.90

Clinical Policy: Digital Breast Tomosynthesis Reference Number: CP.MP.90 Clinical Policy: Reference Number: CP.MP.90 Effective Date: 01/18 Last Review Date: 12/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and

More information

Continuous Glucose Monitoring (CGM)

Continuous Glucose Monitoring (CGM) Continuous Glucose Monitoring (CGM) Date of Origin: 02/2001 Last Review Date: 07/26/2017 Effective Date: 07/26/2017 Dates Reviewed: 04/2004, 04/2005, 03/2006, 11/2006, 12/2007, 03/2008, 09/2008, 04/2009,

More information

Clinical Policy: Posterior Tibial Nerve Stimulation for Voiding Dysfunction Reference Number: CP.MP.133

Clinical Policy: Posterior Tibial Nerve Stimulation for Voiding Dysfunction Reference Number: CP.MP.133 Clinical Policy: Reference Number: CP.MP.133 Effective Date: 10/16 Last Review Date: 10/16 See Important Reminder at the end of this policy for important regulatory and legal information. Coding Implications

More information

DESCRIPTION OF PROCEDURE/SERVICE/PHARMACEUTICAL

DESCRIPTION OF PROCEDURE/SERVICE/PHARMACEUTICAL Subject: Percutaneous Epidural Adhesiolysis for Chronic Low Back Pain (RACZ Procedure) Original Effective Date: 10/12/15 Policy Number: MCP-257 Revision Date(s): Review Date: 12/16/15, 12/14/16, 6/22/17

More information

Acupuncture and its Complementary Role in the Treatment of Cardiovascular Diseases.

Acupuncture and its Complementary Role in the Treatment of Cardiovascular Diseases. Acupuncture and its Complementary Role in the Treatment of Cardiovascular Diseases. Roger Wang A.P., Dr. Huimin Wang Wang s Acupuncture Jacksonville, FL http://wangsacupunctureclinic.com Call for volunteers.

More information

Committee Approval Date: August 15, 2014 Next Review Date: September 2015

Committee Approval Date: August 15, 2014 Next Review Date: September 2015 Medication Policy Manual Policy No: dru152 Topic: Kuvan, sapropterin Date of Origin: March 18, 2008 Committee Approval Date: August 15, 2014 Next Review Date: September 2015 Effective Date: October 1,

More information

Populations Interventions Comparators Outcomes Individuals: With diagnosed heart disease. rehabilitation

Populations Interventions Comparators Outcomes Individuals: With diagnosed heart disease. rehabilitation Protocol Cardiac Rehabilitation in the Outpatient Setting (80308) Medical Benefit Effective Date: 01/01/17 Next Review Date: 05/18 Preauthorization No Review Dates: 07/07, 07/08, 05/09, 05/10, 05/11, 05/12,

More information

Premier Health Plan considers Oral Appliances for Obstructive Sleep Apnea (OSA) medically necessary for the following indications:

Premier Health Plan considers Oral Appliances for Obstructive Sleep Apnea (OSA) medically necessary for the following indications: Premier Health Plan POLICY AND PROCEDURE MANUAL MP.063.PH - al Appliances for Obstructive Sleep Apnea This policy applies to the following lines of business: Premier Commercial Premier Employee Premier

More information

Acupuncture Needles. Overview. Gary Deng, MD,PhD. Traditional Theories. Acupuncture in Cancer Care: the USA Experience. History. Research Activities

Acupuncture Needles. Overview. Gary Deng, MD,PhD. Traditional Theories. Acupuncture in Cancer Care: the USA Experience. History. Research Activities , MD,PhD Acupuncture in Cancer Care: the USA Experience History Overview First ISS-ARTOI Conference on Integrative Oncology Fifth ARTOI International Congress Rome, Italy Nov 7, 2013, MD, PhD Integrative

More information

Clinical Policy: Essure Removal Reference Number: CP.MP.131

Clinical Policy: Essure Removal Reference Number: CP.MP.131 Clinical Policy: Reference Number: CP.MP.131 Effective Date: 11/16 Last Review Date: 11/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and

More information

East Meets West: Treating Pain with Acupuncture

East Meets West: Treating Pain with Acupuncture East Meets West: Treating Pain with Acupuncture Lixing Lao, Ph.D., L.Ac. Professor and Director TCM Research Program, Center for Integrative Medicine University of Maryland School of Medicine Center for

More information

Acupuncture PATIENT INFORMATION SHEET

Acupuncture PATIENT INFORMATION SHEET Acupuncture PATIENT INFORMATION SHEET What is acupuncture? Acupuncture is one component of traditional Chinese medicine that has been used for over 2,000 years to treat many health conditions. It is a

More information

TITLE: Delivery of Electroconvulsive Therapy in Non-Hospital Settings: A Review of the Safety and Guidelines

TITLE: Delivery of Electroconvulsive Therapy in Non-Hospital Settings: A Review of the Safety and Guidelines TITLE: Delivery of Electroconvulsive Therapy in Non-Hospital Settings: A Review of the Safety and Guidelines DATE: 08 May 2014 CONTEXT AND POLICY ISSUES Electroconvulsive therapy (ECT) is a treatment that

More information

HCT Medical Policy. Bronchial Thermoplasty. Policy # HCT113 Current Effective Date: 05/24/2016. Policy Statement. Overview

HCT Medical Policy. Bronchial Thermoplasty. Policy # HCT113 Current Effective Date: 05/24/2016. Policy Statement. Overview HCT Medical Policy Bronchial Thermoplasty Policy # HCT113 Current Effective Date: 05/24/2016 Medical Policies are developed by HealthyCT to assist in administering plan benefits and constitute neither

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: No Coverage Criteria/Off-Label Use Policy Reference Number: CP.PMN.53 Effective Date: 07.01.18 Last Review Date: 05.01.18 Line of Business: Oregon Health Plan Revision Log See Important

More information

HYSTERECTOMY FOR BENIGN CONDITIONS

HYSTERECTOMY FOR BENIGN CONDITIONS HYSTERECTOMY FOR BENIGN CONDITIONS UnitedHealthcare Oxford Clinical Policy Policy Number: SURGERY 104.7 T2 Effective Date: April 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 CONDITIONS OF COVERAGE...

More information

Clinical Policy: EEG in the Evaluation of Headache Reference Number: CP.MP.155

Clinical Policy: EEG in the Evaluation of Headache Reference Number: CP.MP.155 Clinical Policy: EEG in the Evaluation of Headache Reference Number: CP.MP.155 Effective Date: 12/17 Last Review Date: 12/17 Coding Implications Revision Log See Important Reminder at the end of this policy

More information

Texas Vendor Drug Program Specialty Drug List Process. February 2019

Texas Vendor Drug Program Specialty Drug List Process. February 2019 Texas Vendor Drug Program Specialty Drug List Process February 2019 Table of Contents Table of Contents...1 1 About the Specialty Drug List...2 1.1 Information for Pharmacies... 2 1.2 Information for Managed

More information

Subject: Virtual Bronchoscopy and Electromagnetic Navigational Bronchoscopy for Evaluation of Peripheral Pulmonary Lesions

Subject: Virtual Bronchoscopy and Electromagnetic Navigational Bronchoscopy for Evaluation of Peripheral Pulmonary Lesions Subject: Virtual Bronchoscopy and Electromagnetic Navigational Bronchoscopy for Evaluation of Peripheral Pulmonary Lesions Original Effective Date: 8/25/14 Policy Number: MCP-206 Revision Date(s): Review

More information

Clinical Policy: Selective Nerve Root Blocks and Transforaminal Epidural Steroid Injections

Clinical Policy: Selective Nerve Root Blocks and Transforaminal Epidural Steroid Injections Clinical Policy: Selective Nerve Root Blocks and Transforaminal Epidural Steroid Injections Reference Number: CP.MP.165 Last Review Date: 04/18 See Important Reminder at the end of this policy for important

More information

Clinical Policy: Measurement of Serum 1,25-dihydroxyvitamin D

Clinical Policy: Measurement of Serum 1,25-dihydroxyvitamin D Clinical Policy: Reference Number: CP.MP.152 Last Review Date: 12/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description

More information

End Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity

End Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity End Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity October 2, 2018 Note: Computer speakers or headphones are necessary

More information

Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting

Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting Eric B. Durbin, DrPH, MS, Director of Cancer Informatics Frances E. Ross, CTR,

More information

Priorities Forum Statement

Priorities Forum Statement Priorities Forum Statement Number 48 Subject Complementary and Alternative Medicine (CAM) Date of decision August 2016 Date refreshed March 2017 Date of review August 2018 Recommendations GUIDANCE Interventions

More information

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: January 1, Related Policies None

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: January 1, Related Policies None DRUG TESTING POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE 259.2 T0 Effective Date: January 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES

More information

Clinical Policy: Digital EEG Spike Analysis

Clinical Policy: Digital EEG Spike Analysis Clinical Policy: Reference Number: CP.MP.105 Last Review Date: 01/18 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description

More information

Cancer Immunotherapy Pilot Program/ Patents 4 Patients. USPTO BCP Customer Partnership Meeting Alexandria, VA August 2, 2017

Cancer Immunotherapy Pilot Program/ Patents 4 Patients. USPTO BCP Customer Partnership Meeting Alexandria, VA August 2, 2017 Cancer Immunotherapy Pilot Program/ Patents 4 Patients USPTO BCP Customer Partnership Meeting Alexandria, VA August 2, 2017 1 Cancer Immunotherapy Pilot Program/ Patents 4 Patients The United States Patent

More information

Service Line: Rapid Response Service Version: 1.0 Publication Date: January 21, 2019 Report Length: 5 Pages

Service Line: Rapid Response Service Version: 1.0 Publication Date: January 21, 2019 Report Length: 5 Pages CADTH RAPID RESPONSE REPORT: REFERENCE LIST Topical Cantharidin/ Salicylic Acid/ Podophyllin for the Treatment of Warts: Clinical Effectiveness and Guidelines Service Line: Rapid Response Service Version:

More information

North Dakota Board of Pharmacy

North Dakota Board of Pharmacy North Dakota Board of Pharmacy Updates on Drug Abuse Trends, the PDMP and Medical Marijuana Mark J. Hardy, Pharm D Executive Director Disclosure Statement I have no conflict of interests to report Objectives

More information

Clinical Policy: Gastric Electrical Stimulation Reference Number: CP.MP.40

Clinical Policy: Gastric Electrical Stimulation Reference Number: CP.MP.40 Clinical Policy: Reference Number: CP.MP.40 Effective Date: 09/09 Last Review Date: 10/16 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and

More information

Ultrasound Transient Elastography for Liver Fibrosis

Ultrasound Transient Elastography for Liver Fibrosis Ultrasound Transient Elastography for Liver Fibrosis Protocol: RAD042 Effective Date: June 1, 2018 Table of Contents Page COMMERCIAL, MEDICARE & MEDICAID COVERAGE RATIONALE... 1 DESCRIPTION OF SERVICES...

More information

US H.R.6 of the 115 th Congress of the United States Session

US H.R.6 of the 115 th Congress of the United States Session US H.R.6 of the 115 th Congress of the United States 2017-2018 Session This Act may be cited as the Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities

More information

ENTYVIO (VEDOLIZUMAB)

ENTYVIO (VEDOLIZUMAB) ENTYVIO (VEDOLIZUMAB) UnitedHealthcare Community Plan Medical Benefit Drug Policy Policy Number: CS2017D0053F Effective Date: July 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

MEDICAL POLICY SUBJECT: COGNITIVE REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/Rehabilitation

MEDICAL POLICY SUBJECT: COGNITIVE REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/Rehabilitation MEDICAL POLICY SUBJECT: COGNITIVE REHABILITATION PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product (including

More information

Biofeedback as a Treatment of Headache

Biofeedback as a Treatment of Headache Biofeedback as a Treatment of Headache Policy Number: 2.01.29 Last Review: 7/2018 Origination: 7/2008 Next Review: 7/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) may provide coverage

More information

Clinical Policy: Discography

Clinical Policy: Discography Clinical Policy: Reference Number: CP.MP.115 Last Review Date: 06/18 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description

More information

Men s Health Coding & Payment Quick Reference

Men s Health Coding & Payment Quick Reference Payer policies will vary and should be verified prior to treatment for limitations on diagnosis, coding or site of service requirements. The coding options listed within this guide are commonly used codes

More information

Lumify. Lumify reimbursement guide {D DOCX / 1

Lumify. Lumify reimbursement guide {D DOCX / 1 Lumify Lumify reimbursement guide {D0672917.DOCX / 1 {D0672917.DOCX / 1 } Contents Overview 4 How claims are paid 4 Documentation requirements 5 Billing codes for ultrasound: Non-hospital setting 6 Billing

More information

Subject: Temporary Prostatic Stent and Prostatic Urethral Lift

Subject: Temporary Prostatic Stent and Prostatic Urethral Lift 02-54000-21 Original Effective Date: 03/15/05 Reviewed: 09/27/18 Revised: 10/15/18 Subject: Temporary Prostatic Stent and Prostatic Urethral Lift THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION,

More information

Winter Holiday Suicide Myth Continues to be Reinforced in Press Annenberg Public Policy Center Study Finds

Winter Holiday Suicide Myth Continues to be Reinforced in Press Annenberg Public Policy Center Study Finds FOR IMMEDIATE RELEASE DATE: 8 December 2010 CONTACT: Dan Romer, 215-898-6776 (office); 610-202-7315 (cell) Winter Holiday Suicide Myth Continues to be Reinforced in Press Annenberg Public Policy Center

More information

FAQs about Provider Profiles on Breast Cancer Screenings (Mammography) Q: Who receives a profile on breast cancer screenings (mammograms)?

FAQs about Provider Profiles on Breast Cancer Screenings (Mammography) Q: Who receives a profile on breast cancer screenings (mammograms)? FAQs about Provider Profiles on Breast Cancer Screenings (Mammography) Q: Who receives a profile on breast cancer screenings (mammograms)? A: We send letters and/or profiles to PCPs with female members

More information

Clinical Policy: Multiple Sleep Latency Testing

Clinical Policy: Multiple Sleep Latency Testing Clinical Policy: Reference Number: CP.MP.24 Last Review Date: 04/18 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description

More information